leadf
logo-loader
viewSourceBio International PLC
(
AIM:SBI
)

SourceBio International gets set for IPO as Covid-19 testing demand becomes main focus

SourceBio International's (LON:SBI) Jay LeCoque talks to Proactive London's Katie Pilbeam ahead of their IPO on AIM.

He explains that Covid-19 is now their main focus, to support the government effort to get the pandemic testing campaign under control.

The IPO, values the company at £120m, which Jay LeCoque says is the 'right time to do it and the support from the city underscores it's the right decision to do it now.'

Quick facts: SourceBio International PLC

Follow
AIM:SBI

Price: 126 GBX

Market Cap: £93.47 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

FTSE falls deeper into the sea of red as China induced tsunami hits Asian...

FTSE 100 hit more turbulence as China’s clampdown on tech firms continued to hit Asian markets. In London, the blue chip index shed 48 to 6,976. Tesla profits surged ahead in its latest quarter despite shortages of semiconductor chips and distribution problems. Sales jumped to US$12bn with a...

on 27/7/21

2 min read